RECURRENT GRADE 1 FOLLICULAR LYMPHOMA

Clinical trials for RECURRENT GRADE 1 FOLLICULAR LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GRADE 1 FOLLICULAR LYMPHOMA trials appear

Sign up with your email to follow new studies for RECURRENT GRADE 1 FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 10 Completed 1

Double-Punch drug trial aims to knock out stubborn blood cancer

Disease control Recruiting now

This study is testing a combination of two targeted drugs, mosunetuzumab and polatuzumab vedotin, for people with follicular lymphoma that has come back or not responded to previous treatments. The goal is to see if using these two drugs together is safe and can eliminate detecta…

Matched conditions: RECURRENT GRADE 1 FOLLICULAR LYMPHOMA

Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 10, 2026 12:53 UTC

RECURRENT GRADE 1 FOLLICULAR LYMPHOMA

Get alerted when new RECURRENT GRADE 1 FOLLICULAR LYMPHOMA trials appear

Double-Punch drug trial aims to knock out stubborn blood cancer